Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall fentanylFentanyl deaths have reached a frightening level, with another fentanyl product as the subject of an FDA Alert issued in September 2007. Fentora is an extremely potent fentanyl-based pain relief medication prescribed to cancer patients who have already become tolerant to opioid medicines. It comes in a buccal tablet, meaning that the tablet is placed between the teeth and cheek, where it slowly dissolves. A large number of fentanyl deaths from Fentora misuse were reported to the FDA, prompting the Alert and other precautionary messages from the FDA.
Duragesic Pain Patches
It has long been known that fentanyl deaths can also be caused by leaking Duragesic transdermal patches that contain fentanyl. Because of the high potency level of fentanyl (it is at least 80 times stronger than morphine), it is classified as a Schedule II drug and monitored closely by the U.S. DEA (Drug Enforcement Administration).
Two large recalls of Duragesic patches were issued within recent years, following reports of patches whose manufacture was not adequate. Leakage from a transdermal patch resulted in many fentanyl deaths.
Prescribing Errors
Regarding the Fentora tablets, the FDA noted that physicians and other healthcare providers have made several mistakes that resulted in fentanyl deaths, including:
The FDA's September Alert noted that Fentora should not be prescribed for any type of short-term pain such as migraine headaches or pain from a broken bone. As part of the effort to prevent more fentanyl deaths and overdoses, the FDA also asked Cephalon Inc., the maker of Fentora, to improve and clarify the dosage instructions and warnings on the Fentora packaging,
Learn More about Fentanyl Deaths
If a Duragesic fentanyl patch or a Fentora tablet has caused a fentanyl death or overdose in your family, you can learn more about your legal rights from an attorney or law firm in your area. Contact a fentanyl lawyer today to discuss your case.
Actavis Inc. has expanded its recent recall of fentanyl painkiller patches to include all lots sold in the United States. The company said the expansion is a precautionary measure because it cannot guarantee that all patches are without defect.
Another fentanyl patch recall was issued on Monday over a defect that could cause the patches to leak. This is the second recall issued for the prescription patches in the p...
Approximately 32 million fentanyl-containing pain patches are being recalled by Johnson & Johnson over a manufacturing flaw that could lead to unintentional overdose.
The patches, sold under the brand name » Read More